Drug Development Technology is using cookies

We use them to give you the best experience. If you continue using our website, we'll assume that you are happy to receive all cookies on this website.

ContinueLearn More X
X

NextCure begins Phase I/II trial of NC318 for solid tumours

NextCure will investigate the safety and tolerability of NC318 in patients with advanced or metastatic solid tumours. Credit: Yale Rosen.



  • Carcinoma

Go Top